MONTE ROSA THERAPEUTICS INC (GLUE) Stock Analyst Ratings
NASDAQ:GLUE - Nasdaq - US61225M1027 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to GLUE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.05. This target is 244.42% above the current price.
GLUE was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about GLUE.
In the previous month the buy percentage consensus was at a similar level.
GLUE was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-21 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-03-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-12 | LifeSci Capital | Initiate | Outperform |
| 2024-12-19 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-09-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-06-28 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-05-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-15 | Wedbush | Initiate | Outperform |
| 2023-10-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-11 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-05-12 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-03-17 | Credit Suisse | Maintains | Neutral |
| 2023-01-03 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2022-10-13 | UBS | Initiate | Buy |
| 2022-08-15 | Jefferies | Initiate | Buy |
| 2022-05-12 | Piper Sandler | Maintains | Overweight |
| 2022-04-28 | Credit Suisse | Initiate | Neutral |
| 2022-02-10 | Wells Fargo | Initiate | Equal-Weight |
| 2021-10-14 | SVB Leerink | Initiate | Market Perform |
| 2021-07-19 | Guggenheim | Initiate | Buy |
| 2021-07-19 | JP Morgan | Initiate | Overweight |
| 2021-07-19 | Piper Sandler | Initiate | Overweight |